The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?
about
Multiple sclerosis in the Arabian Gulf countries: a consensus statementA fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs.Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship.Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.High risk of cardiovascular diseases after diagnosis of multiple sclerosis.Spectroscopic Investigation of the Interaction of the Anticancer Drug Mitoxantrone with Sodium Taurodeoxycholate (NaTDC) and Sodium Taurocholate (NaTC) Bile Salts.
P2860
The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@ast
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@en
type
label
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@ast
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@en
prefLabel
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@ast
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@en
P2860
P356
P1476
The cardiac effects of mitoxan ...... sclerosis outweigh the risks?
@en
P2093
T Jock Murray
P2860
P304
P356
10.1517/14740338.5.2.265
P407
P577
2006-03-01T00:00:00Z